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ABSTRACT
USP21 is a centrosome-associated deubiquitylase (DUB) that has
been implicated in the formation of primary cilia – crucial organelles for
the regulation of the Hedgehog (Hh) signaling pathway in vertebrates.
Here, we identify KCTD6 – a cullin-3 E3-ligase substrate adapter that
has been previously linked to Hh signaling – as well as Gli1, the key
transcription factor responsible for Hh signal amplification, as new
interacting partners of USP21. We identify a cryptic structured protein
interaction domain in KCTD6, which is predicted to have a similar
fold to Smr domains. Importantly, we show that both depletion
and overexpression of catalytically active USP21 suppress Gli1-
dependent transcription. Gli proteins are negatively regulated through
protein kinase A (PKA)-dependent phosphorylation. We provide
evidence that USP21 recruits and stabilises Gli1 at the centrosome
where it promotes its phosphorylation by PKA. By revealing an
intriguing functional pairing between a spatially restricted
deubiquitylase and a kinase, our study highlights the centrosome as
an important hub for signal coordination.
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INTRODUCTION
Hedgehog (Hh) signaling plays an important role during
development and has also been implicated in diverse
malignancies, including basal cell carcinomas, medullo- and
glioblastoma, as well as pancreatic, colon and breast carcinomas
(Amakye et al., 2013; Takebe et al., 2015). Inhibitors of this
pathway are under assessment in the clinic as potential anti-cancer
therapeutics (Gonnissen et al., 2015; Takebe et al., 2015). The
general architecture of the pathway was initially discovered in
Drosophila (Nusslein-Volhard and Wieschaus, 1980), but much of
the cascade is highly conserved from flies to vertebrates (Briscoe
and Therond, 2013; Ingham et al., 2011). In contrast to many other
signaling pathways, Hh signaling is constitutively repressed by the
interplay of two multi-spanning transmembrane proteins, Patched
(PTC in Drosophila, and PTCH1 and PTCH2 in mammals) and
Smoothened (SMO). In the absence of a signal, Patched proteins
inhibit SMO, and the key transcription factors, Ci (Cubitus
interruptus) in Drosophila, and Gli2 and Gli3 in mammals, are
converted to transcriptional repressors. Gli2 and Gli3 are
phosphorylated by a series of kinases [protein kinase A (PKA),
casein kinase 1 (CK1) and glycogen synthase kinase 3 β (GSK3β)],
and in particular, Gli3 undergoes processing (limited proteolysis) in
a phosphorylation-, ubiquitylation- and proteasome-dependent
manner to a transcriptionally repressive form. Activation of the
pathway is triggered by binding of Hh ligands to PTCH1 or PTCH2,
which triggers their endocytosis and leads to de-repression of SMO,
favouring activation of Ci/Gli proteins. These translocate into the
nucleus and activate expression of Hh-responsive genes (Hui and
Angers, 2011). In mammalian cells, activation of the cascade is
localised at the primary cilium, a specialised microtubule-based
surface organelle. Release of SMO inhibition leads to SMO, Gli2
and Gli3 translocation to the cilium, and subsequent translocation of
the unprocessed transcriptionally active Gli proteins to the nucleus.
One of the transcriptional targets is Gli1, which exclusively
functions as a transcriptional activator in the pathway. It is the
balance of active and repressive Gli proteins that determines signal
strength and outcome.
Post-translational modifications play key roles in this cascade
(Chen and Jiang, 2013; Gulino et al., 2012). Reversible
ubiquitylation can either promote protein degradation, or alter
subcellular localisation or activity of a protein. Multiple E3 ligases
are thought to play crucial roles in Hh signaling – Cullin1 with the
substrate adapter Slimb (in Drosophila) and βTRCP (in mammals),
and Cullin3 with the substrate adapter Roadkill/HIB (inDrosophila)
and SPOP (in mammals) and Itch have all been shown to
ubiquitylate and destabilise Gli proteins (Jiang, 2006).
Approximately 90 deubiquitylases (DUBs) are encoded in the
human genome (Clague et al., 2013; Komander et al., 2009). This
family of enzymes has been implicated in the regulation of many
canonical signal transduction cascades – e.g. NFκB, Wnt, TGFβ
and the Ras–MAPK pathway (Clague et al., 2012a; Hayes et al.,
2012; Keusekotten et al., 2013). USP8 has been associated with this
cascade in Drosophila, where it promotes recycling of SMO
(Clague et al., 2012b; Li et al., 2012; Xia et al., 2012). However, the
role of DUBs in the mammalian Hh-signaling pathway has only
recently been explored (Zhou et al., 2015).
We have previously characterised USP21 as the only centrosome-
and microtubule-associated DUB in a comprehensive localisation
screen (Urbe et al., 2012). USP21 also associates with basal bodies
in ciliated cells, and its depletion inhibits the formation of primary
cilia, which play a crucial role in the initiation of Hh signaling in
vertebrates. Here, we identify a new binding partner of USP21, the
BTB-domain-containing cullin E3-ligase adapter protein KCTD6
(KCASH3), which has previously been implicated in Hh signaling
(De Smaele et al., 2011). Importantly, we go on to show that either
depletion or overexpression of USP21 suppresses Gli1-dependentReceived 24 February 2016; Accepted 5 September 2016
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transcription in human cells. Our results reveal that USP21 stabilises
Gli1 at the centrosome and promotes its phosphorylation by PKA,
thus contributing to the intricate compartmentalisation of the Hh-
signaling pathway.
RESULTS
Identification of new USP21-interacting partners
We have used a yeast two-hybrid (Y2H) approach to search for
directly interacting proteins of USP21 that could act as substrates or
substrate adaptors in the context of microtubule- and centrosome-
dependent processes. Out of a panel of USP21 fragments, only those
encompassing amino acids 1–174 and lacking residues 1–47 passed
the suitability test by failing to auto-activate reporter genes
(Materials and Methods; data not shown). We selected USP21
[Δ1–47], which retains all microtubule-binding and centrosome-
localisation determinants (Urbe et al., 2012), as a bait to screen a
universal normalised human cDNA Y2H library (Fig. 1A). Seven
out of ten isolated diploid colonies contained plasmids with in-
frame annotated coding sequences, two of which encode ZNF350
(zinc-finger protein 350). The other proteins identified were
potassium channel tetramerization domain containing 6 (KCTD6),
WD-repeat-containing protein 47 (WDR47), spectrin-repeat-
containing nuclear envelope 1 (SYNE1), membrane protein
palmitoylated 1 55 kDa (MPP1) and Ankyrin-repeat-domain-
containing protein 32 (ANKRD32) (Table 1, Fig. 1A).
USP21 associates with the BTB-domain protein KCTD6
Two of the six new USP21-interacting proteins have been shown
to localise to microtubule-based structures. WDR47 colocalises
with cytoplasmic microtubules through its interaction with
microtubule-associated protein (MAP)8 (Wang et al., 2012a),
whereas MPP1 has been localised to the basal body and the ciliary
axoneme in murine photoreceptors (Gosens et al., 2007). We were
particularly intrigued by KCTD6, a BTB-domain-containing
protein that has previously been shown to modulate Hh
signaling in association with the related protein KCTD11 (De
Smaele et al., 2011). We validated this interaction by co-
immunoprecipitating epitope-tagged proteins from HEK293T
cells (Fig. 1B). KCTD6 interacts preferentially with catalytically
inactive USP21-C221S (USP21CS), which in turn isolates higher-
molecular-mass species of mono- and di-ubiquitylated KCTD6
(Fig. 1B,C). USP21CS itself presents as a doublet, a phenomenon
commonly observed for catalytically inactive mutants of the USP
family – e.g. USP4 and USP15 – which tend to accumulate as a
mono- and polyubiquitylated species (Fig. 1D) (Hayes et al.,
2012).
USP21 interacts with CUL3 through the BTB-domain protein
KCTD6
KCTD6 binds to CUL3 through its BTB domain, suggesting that it
acts as a classic substrate adapter of a BTB–CUL3–Rbx1 ubiquitin
E3 ligase (De Smaele et al., 2011; Lange et al., 2012; Smaldone
et al., 2015). We asked whether USP21 interacts with a fully
assembled KCTD6–CUL3 ligase complex. Interactions between
DUBs and E3 ligases have been established in the literature, but few
examples have been analysed in detail (Hayes et al., 2012;
Keusekotten et al., 2013; Komander et al., 2009; Schulein-Volk
et al., 2014; Sowa et al., 2009; Villeneuve et al., 2013). Both active
and inactive USP21 co-immunoprecipitate with CUL3 and vice
versa (Fig. 2B; Fig. S1B). Intriguingly, immunoprecipitation of
inactive USP21CS enriches a higher-molecular-mass species of
CUL3 that could in principle correspond to a neddylated form,
which is required for cullin–RING-ligase activation (Bennett et al.,
2010). The Nedd8-activating enzyme (NAE) inhibitor MLN4924
did not affect association of FLAG–KCTD6 with endogenous
CUL3, nor the amount of USP21 that bound to KCTD6 (Fig. S1A).
Importantly, the additional CUL3 band was insensitive to
MLN4924, suggesting that USP21CS promotes the stabilisation
of ubiquitylated forms of both KCTD6 and CUL3 (Fig. S1B).
The interaction between USP21 and CUL3 is most likely
indirect and mediated through KCTD6 given that a functional
BTB domain is both required and sufficient (Fig. 2A,C,D). Two
closely related KCTD-family members have also been implicated
in Hh signaling (Canettieri et al., 2010). The KCTD6-interacting
protein KCTD11 (also called KCASH1 or REN), but not KCTD21
(also called KCASH2), bound weakly to wild-type USP21 and
strongly to catalytically inactive USP21 (Fig. S1C). However, in
contrast to KCTD6, KCTD11 did not appear to be modified in
GFP–USP21CS co-immunoprecipitates.
Identification of a cryptic protein-interaction domain in
KCTD6
The best-characterised BTB-domain CUL3 adaptors contain defined
substrate interaction domains, such as Kelch, MATH, PHR or zinc
fingers (Stogios et al., 2005). No such domains have been described
for KCTD proteins, yet the region comprising residues 114–237,
which is located directly after its BTB domain, is sufficient for
interaction with USP21 (Fig. 3A). The combined results of Y2H and
pull-down analyses narrow down the USP21 binding site to the 114–
187 region of KCTD6 (Fig. 3E). We hypothesised that this region
contains a cryptic protein-interacting domain.
Sensitive bioinformatics tools for detecting distant homologies
(HHpred; Soding, 2005) and the Metaserver used to recognise
protein folds (Bujnicki et al., 2001) failed to identify recognisable
relatives of the KCTD6 C-terminal domain. Nevertheless, the
region is rich in predicted secondary structure, suggestive of a well-
folded domain. In favourable cases, ab initio modelling can
accurately predict the overall fold of a queried protein through
stitching together fragments of unrelated proteins (Rohl et al., 2004;
Xu and Zhang, 2012). Using this approach, the most promising
results were obtained for a region comprising residues 109–213,
eliminating 24 residues from the C-terminus that some methods
indicate might be intrinsically disordered. The favoured model from
the QUARK ab initiomodelling server bears a striking resemblance
to the C-terminal Smr domain of human NEDD4-binding protein 2
(NEDD4BP2), with a Z-score of 7.1 for the match, well above the
threshold of 2 generally taken as indicating significance [PDB code
2VKC (Diercks et al., 2008); Fig. 3B; Fig. S1D]. According to this
model, the C-terminal section (residues 188–213) of this Smr-like
(SmrL) domain, containing a helix and a short β-hairpin, is separate
from the remainder of the structure, which thus might be able to fold
independently. Indeed, separate ab initio modelling efforts using a
shorter stretch of the peptide, comprising residues 109–187,
produced results that included structures similar to those of the
modelled SmrL domain (not shown). This might account for the
observed association of USP21 with a C-terminally truncated
KCTD6 (residues 114–187) in our Y2H screen.
Conversely the Δ1–184 fragment, encompassing the catalytic
domain of USP21, is necessary and sufficient to bind to KCTD6 as
well as to CUL3 (Fig. 3C,D). Taken together, our data indicate that
CUL3, KCTD6 and USP21 can form a multimeric complex in
which the catalytic domain of USP21 interacts with the C-terminal
SmrL domain of KCTD6, whereas the BTB domain of the latter
mediates interaction with CUL3 (Fig. 3E).
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Fig. 1. USP21 interacts with KCTD6, a component of the BTB–CUL3–Rbx1 ubiquitin E3-ligase complex. (A) A Y2H screen of a normalised human cDNA
library using USP21[Δ1–47] as the bait identified the CUL3-substrate-adapter protein KCTD6 (amino acids 1–187). USP, ubiquitin-specific protease; BTB, broad-
complex, Tramtrack and Bric-a-brac. An Smr-like domain (SmrL) was identified by ab initiomodelling (see Fig. 3). (B) Validation of the interaction of USP21 with
KCTD6 in human cells. HEK293T cells were transfected with FLAG–KCTD6 and GFP, GFP–USP21 or GFP–USP21CS. Lysates were subjected to
immunoprecipitation (IP) with anti-GFP or anti-FLAG antibodies. IB, immunoblot. (C) Inactive USP21 co-precipitated ubiquitylated KCTD6. Lysates were used for
immunoprecipitation with an anti-GFP antibody. Interacting proteins were analysed by western blotting with anti-FLAG and anti-Ubiquitin (P4G7) antibodies. Exp,
exposure (B,C). Arrowheads indicate mono- (<) and di- (<<) ubiquitylated species of KCTD6. Arrow indicates unmodified KCTD6. (D) The higher-molecular-mass
form of USP21-C221S (arrow) corresponds to a monoubiquitylated species. Lysates from the experiment shown in C were subjected to immunoprecipitation with
anti-GFP antibodies and probed in parallel with anti-ubiquitin or anti-GFP antibodies.
4003
RESEARCH ARTICLE Journal of Cell Science (2016) 129, 4001-4013 doi:10.1242/jcs.188516
Jo
u
rn
al
o
f
Ce
ll
Sc
ie
n
ce
USP21 does not affect KCTD6 and CUL3 protein levels
Based on previously described interactions between DUBs and E3
ligases, we asked whether USP21 might either stabilise or modulate
the activity of the KCTD6–CUL3 E3-ligase complex. Neither small
interfering (si)RNA-mediated depletion nor overexpression of
USP21 altered overall CUL3 protein levels or the relative
proportions of active (neddylated) and inactive (non-neddylated)
forms (Fig. S2A,B). Unfortunately, none of the commercially
available antibodies against KCTD6 that we tested recognised the
endogenous protein. FLAG–KCTD6 protein levels were not
significantly affected by overexpression of USP21 (Fig. 1B). We
conclude that despite the enrichment of ubiquitylated KCTD6 and
CUL3 in USP21CS immunoprecipitates, the stability of both proteins
is not regulated by USP21. The steady-state protein levels of the sole
known substrate of the previously described substrate of the
previously described heterodimeric CUL3 E3-ligase substrate
adapter complex KCTD6–KCTD11, HDAC1, were also unaffected
by depletion or overexpression of USP21 (Fig. S2C,D).
USP21 regulates the Hh-signaling pathway and modulates
Gli1 transcriptional activity
KCTD6 has been proposed to act as a negative regulator of the Hh-
signaling pathway (De Smaele et al., 2011). We have previously
shown that USP21 depletion inhibits the formation of the primary
cilium, which also plays a key role in Hh pathway activation in non-
transformed cells. In order to assess a potential role of USP21 in Hh
signaling, we first measured Gli1 mRNA levels as a transcriptional
readout in NIH3T3 cells that had been stimulated with a
Smoothened agonist (SAG) (Chen et al., 2002). Depletion of
USP21 inhibited SAG-dependent accumulation of endogenous Gli1
mRNA levels (Fig. 4A).
The main transcriptional activator in the pathway is Gli1 itself,
which operates through a positive auto-regulatory feedback loop
(Hui and Angers, 2011). KCTD6, in concert with KCTD11, has
previously been shown to target HDAC1 for ubiquitin-dependent
degradation, thereby indirectly modulating the acetylation status
and thus transcriptional activity of Gli1. With that in mind, we
wanted to assess the ability of USP21 to affect Gli1 transcriptional
activity in the absence of extrinsic pathway activation using a Gli1-
dependent dual luciferase reporter gene assay. We opted for a
heterologous co-expression system of hemagglutinin-tagged Gli1
(HA–Gli1) and GFP–USP21 in HEK293T cells, which permit high
levels of transfection efficiency. Importantly, this approach
introduces constitutively expressed Gli1 together with the Gli1-
dependent reporter construct into the cells. This allows us to
pinpoint the stage at which USP21 could regulate Hh signaling,
downstream of SMO activation – i.e. downstream of the already
established role in primary cilium formation. In this assay, siRNA-
mediated depletion of USP21 decreased Gli1 transcriptional activity
by ∼40% (Fig. 4B). Likewise, overexpression of GFP–USP21
inhibited Gli1 transcriptional activity to a similar degree, and this
inhibition depended on its catalytic activity (Fig. 4C). Altogether,
these data indicate that USP21 regulates the Hh-signaling pathway,
and either directly or indirectly modulates Gli1 transcriptional
activity.
USP21 interacts with and stabilises Gli1
We asked whether USP21 regulates the stability of Gli1 and turned
to CRISPR-CAS9 technology to knockout USP21 in HEK293T
cells, which, like many cancer cells, show autonomous expression
of Gli1 (Fig. S3A) (Dahmane et al., 1997; Kinzler et al., 1987;
Mazza et al., 2013; Nolan-Stevaux et al., 2009; Tariki et al., 2014).
Transient transfection with plasmids encoding both CAS9–GFP and
five distinct guide (g)RNAs, targeting the second exon
encompassing the start codon of all annotated USP21 isoforms,
resulted in a clear decrease of Gli1 protein levels by 25–50%
(Fig. 5A). Note that in this configuration, residual USP21 could
derive from non-transfected cells. Although these results suggest
that USP21 stabilises Gli1, the observed decrease in endogenous
Gli1 levels could, in principle, reflect transcriptional suppression
(see also Fig. 4A).
We next co-expressed HA-tagged Gli1 together with GFP–
USP21 and fragments thereof in HEK293T cells. We observed a
clear increase in Gli1 protein levels in cells that co-expressed full-
length USP21 (Fig. 5B; Fig. S3B). In order to assess a potential
interaction between these two proteins, we immunoprecipitated
HA–Gli1 and probed for associated GFP–USP21. Full-length GFP–
USP21, but not the shortest N-terminal fragments (comprising
residues 1–120 or 1–174), associated with Gli1 (Fig. 5C). Both the
unstructured N-terminal region (residues 1–210), required for
microtubule and centrosome association, and the C-terminal
USP21 region lacking residues 1–184 and harbouring the catalytic
domain, were capable of binding to Gli1 independently of each
other. Likewise, FLAG-tagged Gli1 and Gli2 were able to co-
precipitate Myc-tagged USP21 from HEK293T cells (Fig. S3C,D).
Having shown above that the catalytic domain of USP21 also
interacts with the KCTD6–CUL3 E3-ligase complex, we wondered
whether KCTD6 would be able to influence Gli1 stability in this
setting. Co-expression of KCTD6 with USP21 counteracted its
ability to stabilise Gli1 (Fig. 5D). This suggests that the direct
interaction of KCTD6 with the USP21 catalytic domain disrupts its
regulation of Gli1.
USP21 stabilises a phosphorylated form of Gli1
The increase of Gli1 protein levels upon USP21 overexpression
appears to be at odds with the observed inhibition of Gli1
transcriptional activity in this setting (Fig. 4C). On close
inspection, we observed a higher molecular weight form of Gli1 in
USP21-overexpressing cells, indicative of a post-translational
Table 1. Identification of potential interacting proteins of USP21 by
yeast two-hybrid using a human normalised library
Clone
number Protein name
NCBI
gene ID
Fragment in prey
(amino acid
residues)
1 BTB/POZ-domain-
containing protein
KCTD6
200845 1–187
2 WD-repeat-containing
protein 47 (WDR47)
22911 685–927
3 Spectrin-repeat-containing
nuclear envelope 1
(SYNE1)
23345 2940–3140
4 Zinc-finger protein 350
(ZNF350)
59348 292–530
5 Zinc-finger protein 350
(ZNF350)
59348 291–415
6 Membrane protein
palmitoylated 1 55 kDa
(MPP1)
4354 318–466
7 Ankyrin-repeat-domain-
containing protein 32
(ANKRD32)
84250 802–1058
Seven clones encoding six new candidate interacting proteins for USP21 were
isolated from a human normalised prey cDNA library using a bait construct of
USP21 that comprised amino acids 48–565.
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modification (Fig. 6A). The intensity of this band was substantially
reduced in cells that co-expressed the catalytically inactive
USP21CS, and the band was absent in cells that expressed
truncated versions of USP21 (Fig. S3B). Many components of the
Hh-signaling pathway are regulated by acetylation, phosphorylation,
ubiquitylation and sumoylation (Chen and Jiang, 2013; Gulino et al.,
2012). In particular, Gli transcriptional activity is regulated by
several kinases, thus we assessed whether USP21 induces Gli1
phosphorylation. Incubation of immunoprecipitated HA–Gli1 with
calf intestinal alkaline phosphatase (CIP) induced loss of the upper
band that was only present in cells that overexpressed full-length
USP21 (Fig. 6B).
Phosphorylation of Gli transcription factors can either activate or
inhibit their transcriptional activity. In the absence of pathway
activation, sequential phosphorylation of Gli3, and to a lesser extent
of Gli2, by PKA, CKI and GSK3β induces ubiquitin-dependent
Fig. 2. Indirect interaction of USP21 with cullin-3. (A) Diagram of the featured CUL3 constructs: full-length CUL3, a BTB-domain-binding mutant (CUL3m) and
a dominant-negative C-terminal truncation mutant [CUL3(1–250)]. Asterisks indicate point mutations (see Materials and Methods). (B) USP21 interacts with
CUL3 in HEK293T cells. HEK293T cells were transfected as indicated, and lysates were subjected to immunoprecipitation (IP) with anti-GFP and anti-FLAG
antibodies as appropriate. Asterisk indicates a higher-molecular-mass form of FLAG–CUL3. (C,D) HEK293T cells were co-transfected with USP21 and with
either CUL3m (C) or with CUL3(1-250) (D). Protein lysates were subjected to immunoprecipitation with anti-GFPor anti-FLAG antibodies. The interacting proteins
were analysed by western blotting (IB) with anti-GFP and either anti-CUL3 or anti-FLAG antibodies as indicated: USP21(/CS), USP21 and USP21-C221S.
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limited proteolysis to generate a transcriptionally repressive form,
GliR (Briscoe and Therond, 2013; Hui and Angers, 2011).
Phosphorylation by PKA alone leads to inactivation of Gli2 and
Gli3 (Niewiadomski et al., 2014; Tuson et al., 2011), and has been
proposed to inhibit nuclear localisation of Gli1 (Sheng et al., 2006).
Finally, phosphorylation of Gli1 by ribosomal protein S6 kinase B1
in response to mTOR activation triggers its release from the
repressor SuFu, leading to its transcriptional activation (Wang et al.,
2012b). Guided by our functional experiments that indicated an
inhibitory role of USP21 expression on Gli1-dependent
transcription (Fig. 4C), we focused on PKA-dependent
phosphorylation as a potential effect of USP21 activity. Co-
Fig. 3. Mapping the interaction between
USP21 and KCTD6–CUL3 E3-ligase
complex. (A) USP21 interacts with KCTD6
[114–237]. HEK293T cells were transfected
with full-length (FL) or truncated KCTD6, GFP
or GFP–USP21, and immunoprecipitations
(IPs) were performed and analysed as
indicated. IB, immunoblot. (B) The overall fold
similarity between the favoured QUARK ab
initio model of the KCTD6 Smr-like domain
[SmrL (109–213)] and the C-terminal Smr
domain of human NEDD4BP2 (PDB code
2VKC; Diercks et al., 2008). Each is coloured in
a spectrum from blue (N-terminus) to red (C-
terminus). A broken line indicates the boundary
between the functionally dispensable C-
terminal region [188–213] and the remainder.
(C,D) HEK293T cells that had been transfected
with FLAG–KCTD6 (C) or FLAG–CUL3 (D),
and GFP-tagged USP21 fragments were lysed
in RIPA buffer. Protein lysates were used for
immunoprecipitation with an anti-GFP antibody.
Asterisk indicates a monoubiquitylated form of
FLAG–KCTD6. (E) Diagram summarising the
interactions between USP21, KCTD6 and
CUL3, components of the BTB–CUL3–Rbx1
E3-ligase complex. Residues 185–565 in
USP21 encompass the necessary elements for
the interaction with KCTD6 (residues 114–187).
Cullins share a homologous C-terminus that
interacts with the RING-finger protein Rbx1.
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expression of PKI, a well-established PKA-inhibitor (Scott et al.,
1985), abolished the USP21-induced accumulation of
phosphorylated Gli1 (Fig. 6C). Strikingly, the decrease of Gli1
phosphorylation was concomitant with a decrease in its protein
levels, suggesting that USP21-induced phosphorylation of Gli1 is
coupled with its stabilisation (Fig. 6C). Similarly, a pool of Gli2
appeared to be stabilised in a PKI-sensitive manner through co-
expression of USP21 (Figs S3C,D and S4A). Altogether, these data
indicate that USP21 stabilises inactive Gli1 and promotes its
phosphorylation by PKA.
USP21 promotes Gli1 localisation at the centrosome
How then could the deubiquitylase USP21 induce Gli1
phosphorylation by PKA? We have previously reported that
USP21 is most highly enriched at the centrosomes and basal
bodies of ciliated cells (Urbe et al., 2012). PKA has previously been
shown to be enriched and active at these two locations (Nigg et al.,
1985; Terrin et al., 2012; Tuson et al., 2011). U2OS cells allow
ready discrimination of intracellular structures owing to their planar
geometry and expanded cytoplasm. In these cells, endogenous PKA
colocalised with GFP–USP21 at the centrosome (Fig. 6D). Neither
wild-type or catalytically inactive USP21 affected PKA protein
levels (Fig. S4B). Given that full stabilisation of phosphorylated
Gli1 requires the USP21 N-terminal microtubule and centrosome-
targeting sequence, we asked whether USP21 influences the
localisation of Gli1. Expressed on its own, HA–Gli1 presents with
a diffuse, cytoplasmic and nucleoplasmic localisation. However,
co-expression of either wild-type or catalytically inactive GFP–
USP21 strongly promoted its recruitment to the centrosome
(Fig. 6E).
DISCUSSION
USP21 interacts with KCTD6, a CUL3 substrate adapter,
through its catalytic domain
Our genome-wide Y2H screen yielded six new interacting proteins
of USP21. The fact that WDR47 and MPP1 have been shown
previously to associate with microtubules or the basal body and
axoneme, respectively, makes these likely prospects for future
studies (Gosens et al., 2007; Wang et al., 2012a). Here, we have
focused exclusively on KCTD6, a CUL3-binding BTB protein that
has previously been implicated in the Hh-signaling pathway. This
pathway is of particular interest to USP21 function owing to its
prominent association with centrosomes, basal bodies, microtubules
and primary cilia. We have mapped this interaction to the catalytic
domain of USP21 and a new cryptic protein-interaction domain,
here called Smr-like (SmrL), that is unique to KCTD6. The Smr
domain is generally associated with nuclease function (Fukui et al.,
2007). However, the KCTD6 SmrL does not bear the positively
charged surface of the NEDD4BP2 Smr structure that is
characteristic of DNA- and RNA-binding proteins, nor a suitably
Fig. 4. USP21 modulates Hh signaling and Gli1 transcriptional activity. (A) NIH3T3 cells were treated with USP21-targeting siRNA oligonucleotides
(#10, #11, #12) or a non-targeting control (NT3), serum-starved and then incubated with SAG (100 nM) for 4 h before mRNA extraction. USP21 and Gli1 mRNA
levels were measured by performing quantitative reverse-transcription PCR and normalised to RNA levels of Pol2 (n=3 independent experiments, mean±s.d.).
x-axis labels given in bottom panel also apply to the top panel. (B) HEK293T cells were treated with USP21-targeting siRNA oligonucleotides (#5, #6) or non-
targeting control oligo (NT3), or were treated with transfection reagent alone (Mock). 24 h before lysis, cells were transfected with Gli-responsive firefly luciferase
and Renilla luciferase reporters (pGLB3B-12Gli-Luc and pRL-Renilla-TK), as well as with a Gli1 expression construct (HA–Gli1). Efficiency of the knockdown
was assessed by western blotting (n=2, bars show the range). (C) HEK293T cells were transfected with Gli-responsive firefly luciferase, Renilla luciferase
reporters, HA–Gli1 and the indicated amounts of GFP, GFP–USP21 or GFP–USP21CS plasmids. Protein expression was assessed by western blotting
(IB, immunoblot) for GFP. (GFP, n=5; USP21 and USP21CS, n=6; mean±s.d.; one-way ANOVA and Dunnett’s test, **P<0.01, ****P<0.0001).
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Fig. 5. USP21 regulates Gli1 expression levels. (A) USP21 knockout results in a decrease in endogenous Gli1 protein. HEK293T cells were transfected with
plasmids encoding both Cas9–GFP and one of five independent CRISPR gRNAs targeting USP21 (USP21 gRNA or gUSP21). Cells were lysed in RIPA lysis
buffer 72 h after transfection. Protein lysates were assessed by western blotting (a representative blot is shown). Arrow indicates the major USP21 isoform
(63 kDa) (Okuda et al., 2013). The scatter plot illustrates the close correlation betweenUSP21 andGli1 protein levels (relative to actin) across conditions. Pink and
blue dots indicate Mock and USP21 gRNA, respectively. (B) USP21 overexpression increases Gli1 protein levels. HEK293T cells were co-transfected with the
indicated plasmids, where square brackets indicate the USP21 truncated mutants. Protein lysates were evaluated by western blotting (IB, immunoblot). (C)
USP21 interacts with Gli1. Lysates shown in B were subjected to immunoprecipitation with an anti-HA antibody. (D) KCTD6 counteracts USP21-dependent Gli1
stabilisation. HEK293T cells were transfected with HA–Gli1 and GFP–USP21 with increasing amounts of FLAG–KCTD6. Protein lysates were assessed by
western blotting. (n=3; mean±s.d.; one-way ANOVA and Dunnett’s test, *P<0.05, **P<0.01).
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positioned catalytic Glu residue (Zhang et al., 2014). Browsing the
SCOP structure classification database (http://scop.mrc-lmb.cam.ac.
uk/scop; Andreeva et al., 2008), at the level of protein folds that
contain Smr domains, reveals a second theme of protein–protein
interactions that is exemplified by bacterial sulphurtransferase TusA
(Shi et al., 2010) and by the predicted dimeric form of NEDD4BP2
(according to the PISA resource; http://www.ebi.ac.uk/pdbe/pisa;
Krissinel and Henrick, 2007). This is clearly consistent with the
Fig. 6. See next page for legend.
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protein–protein interaction role determined here for the KCTD6 C-
terminal domain and is supported by existing precedents of the same
fold serving both DNA- and protein-binding functions, e.g. zinc
fingers (Matthews and Sunde, 2002). The newly identified SmrL
domain is restricted to KCTD6, although KCTD11 and KCTD21
could harbour their own distinct cryptic domains adjacent to the
BTB domain. KCTD11, but not KCTD21, has been shown to
heterodimerise with KCTD6, providing a possible explanation for
its interaction with USP21 in pull-down experiments. USP21,
unlike many other members of the USP family, does not contain
insertions in its catalytic domain that could encode additional
protein interaction motifs or domains. Thus, KCTD6 is the first
protein, besides ubiquitin [and ISG15 (Ye et al., 2011)], to be
identified as interacting with the catalytic core of USP21, and is a
rare example of a core binding protein considering the USP family
as a whole.
What then is the role of this interaction? E3-ligase–DUB
interactions can protect the ligases from autoubiquitylation [e.g.
MDM2 stabilisation by USP7 (Cummins and Vogelstein, 2004),
BRAP/IMP stabilisation by USP15 (Hayes et al., 2012)].
Alternatively, the interactions might limit the levels of the
respective DUBs or exert fine control over a common substrate.
We have not found evidence that USP21 and KCTD6 have
reciprocal effects on the stability of the other, nor does USP21 affect
global CUL3 stability or neddylation status. However, the fact that
co-expression of catalytically inactive USP21 results in the
accumulation of minor mono- and di-ubiquitylated species of
KCTD6 and CUL3 indicates the potential for USP21 to modulate
their ubiquitylation status. Alternatively, USP21 could be acting
directly to deubiquitylate the substrates of the cullin RING ligase, in
an analogous fashion to USP28, which associates with the cullin-1-
adapter FBW7 to deubiquitylate a range of substrates, including
MYC (Schulein-Volk et al., 2014). In contrast to FBW7, we
have very little knowledge of the substrates targeted by KCTD6.
The closely related BTB proteins KCTD11 and KCTD21
undergo hetero- and homodimerisation to target HDAC1 for
CUL3-dependent ubiquitylation and degradation (Canettieri et al.,
2010). Degradation of HDAC1 promotes the accumulation of
transcriptionally inactive acetylated Gli1. De Smaele and colleagues
have reported that KCTD6, despite lacking a binding site for
HDAC1, could dimerise with its paralogue KCTD11 (but not
KCTD21) and contribute to HDAC1 ubiquitylation and degradation
(De Smaele et al., 2011). Although we cannot exclude that USP21
directly stabilises KCTD6 substrates, we have not observed any
global effects on HDAC1 protein levels in response to siRNA-
mediated depletion or overexpression of USP21.
USP21, a new regulator of the Hh-signaling pathway
Our results suggest that endogenous USP21 positively regulates
Hh signaling through two independent mechanisms: firstly, we have
previously shown that USP21 depletion interferes with the
formation of primary cilia, the specialised organelles that host the
initiation of the Hh-signaling cascade in untransformed mammalian
cells (Goetz and Anderson, 2010; Urbe et al., 2012). Secondly, we
now show that depletion of USP21 not only inhibits SAG-induced
transcription in ciliated NIH3T3 cells but also directly interferes
with Gli1-dependent activation of a Gli-promoter-driven luciferase
reporter in Gli1-transfected HEK293T cells. Although HEK293T
cells have previously been shown to be capable of generating
primary cilia (Gerdes et al., 2007; Lancaster et al., 2011), under the
conditions of our assay (48 h in 0.5% fetal bovine serum) only 30%
of cells do so. Whereas we cannot exclude that some aspects of
exogenous Gli1-activation rely on primary cilium formation, taken
together, our data showing (1) an interaction between USP21 and
Gli1, (2) the regulation of PKA-dependent phosphorylation of
Gli1 by USP21, and (3) the colocalisation of all three proteins at the
centrosome in U2OS cells make a strong case for a regulatory role of
USP21 that could be independent of cilium formation.
This positions USP21 downstream of SMO and Patched proteins,
and highlights its potential as a new drug target to counteract Hh
signaling. This could be of particular relevance in tumours that
express aberrant levels of Gli1 or that are otherwise activated
downstream of Patched proteins and are thus resistant to the SMO
inhibitor Vismodegib (Amakye et al., 2013). In this context, it is
interesting to note that USP21 has been identified in a large-scale
screen as one of only few genes that has a significantly increased
copy number count in breast tumour samples (Kan et al., 2010). The
fact that both depletion and overexpression of USP21 interfere with
Gli1-dependent transcription suggests that appropriate USP21
protein levels are key to ensuring optimal Hh-signaling outputs.
A dual role of USP21 in stabilising phosphorylated Gli1 at the
centrosome
Intriguingly, overexpression of USP21 represses Gli1-dependent
transcription, despite the fact that the total amount of Gli1 is clearly
increased. Associated with this, we observed the accumulation of a
phosphorylated pool of Gli1 in USP21-overexpressing cells.
Although we have not identified the phosphorylation sites in this
study, we provide evidence for the kinase involved in this
modification. PKA has recently been shown to phosphorylate
multiple serine residues that are conserved in all Gli proteins and to
suppress Gli activity in the absence of a Hh signal (Niewiadomski
et al., 2014). Our results suggest that USP21 overexpression
facilitates these phosphorylation events by recruiting Gli1 either
directly or indirectly to the centrosome, which harbours active PKA
(Terrin et al., 2012). In ciliated cells, USP21 is localised at the
centrosome-derived basal body, where PKA is thought to act on Gli
proteins travelling to and from the cilium (Tuson et al., 2011).
Fig. 6. USP21 recruits Gli1 to the centrosome and promotes its
phosphorylation by PKA. (A) HEK293T cells were transfected with the
indicated plasmids for 24 h. Protein expression was assessed by western
blotting (IB, immunoblot) for HA and GFP. Graph shows the quantification of
the upper form of HA–Gli1 (n=3, mean±s.e.m.; one-way ANOVA and Dunnett’s
test, **P<0.01). (B) HEK293T cells were lysed 24 h after transfection with the
indicated plasmids; immunoprecipitated (IP) HA–Gli1 was incubated with
alkaline phosphatase (CIP) at 30°C for 1 h. Red arrowheads (<) indicate the
upper phosphorylated band. (C) HEK293T cells were transfected with HA–
Gli1, GFP or GFP–USP21 and increasing amounts (µg) of PKI–Cherry or RFP
control. Cells were lysed 24 h after transfection. Protein levels were assessed
by western blotting with anti-HA and anti-RFP antibodies, and membranes
were re-probed for GFP. (D) USP21 colocalised with the catalytic subunit of
PKA (PKAC, PRKACA) at centrosomes. U2OS cells were transfected with
GFP–USP21 or GFP alone as a control. After methanol fixation, cells were
stained with anti-PKAC (red) and anti-pericentrin (blue) antibodies. Images
were captured with a 3i spinning-disk confocal microscope (63× objective).
(E) USP21 and Gli1 colocalize at the centrosome. U2OS cells were co-
transfected with HA–Gli1 and GFP–USP21 or GFP–USP21CS. After
methanol fixation, cells were stained for Gli1 (red) and pericentrin (blue).
Images were captured with a 3i spinning-disk (63× objective). Pearson
correlation coefficients for Gli1 or GFP colocalisation with pericentrin were
calculated on ≥33 cells per condition (mean±s.e.m.). Scale bars: 10 µm. (F) A
working model illustrating the dual role of USP21 in regulating Gli1. USP21
recruits Gli1 at the centrosome and thereby promotes consequential
phosphorylation by PKA. PKA could act as a priming kinase for further
phosphorylation and ubiquitylation events. Wild-type, but not catalytically
inactive USP21, is able to stabilise the labile pool of phosphorylated Gli1. The
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USP21 might thus promote coincidence of substrate and kinase at
these locations. Our data suggest that expression levels of USP21
need to be tightly regulated because both its depletion and
overexpression can hamper Hh signaling. However, the role of
USP21 exceeds that of an adapter, given that both localisation
determinants and catalytic activity are required for maximal
stabilisation of phosphorylated Gli1 (Fig. 5B; Fig. S3A). It is
conceivable that USP21 regulates both the phosphorylation status
and the stability of Gli1 (and possibly Gli2) at the centrosome
(Fig. 6F). Our finding provides a unique illustration of the close
interplay of a DUB and a kinase at this location, and supports the
concept of centrosomes functioning as intracellular signaling hubs
or scaffolds (Arquint et al., 2014).
A recent report has identified USP7 as a DUB that is able to
stabilise Gli-proteins, by opposing several Ubiquitin–E3-ligase
complexes [Cullin1 (Slimb/βTRCP), Cullin3 (HIB/SPOP) and the
HECTE3-ligase ITCH] that are involved inGli protein processing or
degradation in the absence and presence of Hh, respectively (Zhou
et al., 2015). Our results suggest a more complex scenario in which
the restricted localisation of USP21 facilitates the accumulation of an
inactive pool of Gli1 at the centrosome. Extending this model to the
basal body provides a means of orchestrating Gli protein activity
upon entry into or exit from the primary cilium.
MATERIALS AND METHODS
Yeast two-hybrid screen
The coding sequence for USP21[Δ1-47] was subcloned from pCR4-TOPO-
USP21[Δ1-47] into the pGBKT7 vector (Clontech). The resultant
pGBKT7-USP21[Δ1-47] plasmid was sequence verified and transformed
into Y2HGold yeast cells. Single colonies that failed to autonomously
activate the reporter genes in the absence of prey proteins on tryptophan-
lacking X-α-Gal plates, tryptophan-lacking X-α-Gal Aureobasidin-A plates
and tryptophan-, adenine- and histidine-lacking X-α-Gal Aureobasidin-A
plates were selected for the mating procedure. Briefly, Y2HGold pGBKT7-
USP21[Δ1-47] cells were incubated with the human normalised cDNA
Y187 prey library (Clontech) in yeast extract-peptone-adenine-dextrose
(2×YPAD) medium for 23 h at 30°C. More than 2.4×106 diploid clones
were screened and selected for 5 days on synthetic dropout –Trp −Leu X-α-
Gal Aureobasidin-A plates. Twenty clones were picked and streaked onto
synthetic dropout –Trp –Leu –His−Ade X-α-Gal Aureobasidin-A plates for
7 days. Interacting proteins were identified by yeast colony PCR and
subsequently by sequencing of the extracted plasmid.
Cell culture and transfection
U2OS, HEK293T and NIH3T3 cells were cultured in Dulbecco’s modified
Eagle medium (DMEM)with Glutamax (Gibco, Carlsbad, CA).Mediawere
supplemented with 10% FBS, 1% nonessential-amino-acid solution and 1%
penicillin-streptomycin. All cell lines were routinely tested for mycoplasma
contaminations. Transfection of plasmids into HEK293T and U2OS cells
was performed with Genejuice (Novagen). For the dual luciferase reporter
assays (Promega), plasmids were transfected with Lipofectamine 2000
(Invitrogen) into HEK293T cells (DMEM, 0.5% FBS). Cells were fixed or
lysed 24 h after transfection. For siRNA experiments, cells were treated with
non-targeting (NT3) or target-specific siRNA oligonucleotides (Dharmacon
On-Target Plus, Thermo Fisher Scientific; Table S1) at 40 nM final
concentration, once or twice over a period of 96 h (HEK293T) or 120 h
(U2OS). NIH3T3 cells were treated with a 12 nM final concentration, twice
over a period of 120 h. All siRNA experiments were performed using
RNAiMAX (Invitrogen). For Hh-pathway activation, the NIH3T3 cells
were first serum-starved in DMEM with Glutamax for 24 h before addition
of 100 nM SAG or DMSO for 4 h.
Quantitative reverse-transcription PCR
Cells were lysed, and mRNA was extracted using the RNAeasy mini kit
(Qiagen). cDNA synthesis was performed using 1 µg RNAwith RevertAid
H-minus M-MuLV reverse transcriptase (Fermentas) using an oligo-dT
primer (Promega). Quantitative real-time reverse-transcription PCR was
performed in triplicate using iTaq Universal SYBR Green Supermix and a
CFX Connect Real-Time PCR detection machine (Bio-Rad). Primer
sequences are listed in Table S2.
Co-immunoprecipitation
HEK293T cells were transfected with a total of 2.4 µg of DNA per 1×106
cells. At 24 h after transfection, the cells were washed in cold PBS and lysed
in RIPA lysis buffer (10 mM Tris-HCl pH 7.5, 150 mM NaCl, 1% NP40,
0.1% SDS, 1% sodium deoxycholate) or in NP40-lysis buffer (0.5% NP40,
25 mM Tris-HCl pH7.5, 100 mM NaCl, 50 mM NaF) supplemented with
10 mM N-ethylmaleimide, mammalian protease inhibitor (Sigma) and
phosphatase inhibitor cocktail (Roche). Lysates were incubated with
primary antibodies and protein-G– or protein-A–agarose beads (P4691
and P2670, Sigma) or with anti-FLAGM2 Affinity Gel (Sigma, A2220) for
1 h at 4°C. Beads were washed with RIPA or YP-IP buffer (0.1% NP40,
25 mM Tris-HCl pH 7.5 and 150 mM NaCl) 3–5 times and once with
10 mM Tris-HCl pH 7.5. Immunoprecipitated samples and 10 µg of the
input were evaluated by western blotting.
Western blot analysis
Cultured cells were lysed with RIPA or NP40 lysis buffers (see above).
Proteins were resolved using SDS-PAGE (Invitrogen NuPage gel 4–12%),
transferred to nitrocellulose membrane and probed with primary antibodies
over night. For anti-ubiquitin antibodies, membranes were boiled for 30 min
in distilled water and then blocked with 0.5% fish skin gelatin in TBST.
Otherwise, blocking and antibody solutions contained 5% milk.
Visualisation and quantification of western blots were performed using an
Odyssey infrared scanner (LI-COR Biosciences, Lincoln, NE).
Antibodies, plasmids and reagents
Antibodies were as follows: anti-USP21 (Sigma, HPA028397; 1:1000),
anti-Gli1 (clone L42B10, Biolabs, 2643S; 1:1000), anti-CUL3 (Bethyl,
A301-109A; 1:1000), anti-ubiquitin (clone P4G7, Covance, MMS-258R;
1:1000), anti-HA (clone 16B12, Covance, MMS-101P; 1:1000),
Polyclonal anti-FLAG (Sigma, F7425; 1:1000), Monoclonal anti-FLAG
(clone M2, Sigma, F3165; 1:1000), anti-GFP and anti-RFP (sheep and
rabbit, respectively, gift of Ian Prior, University of Liverpool, Liverpool,
UK; 1:1000), anti-β-actin (Abcam, ab6276; 1:5000), anti-pericentrin
(Abcam, ab4448; 1:1000), anti-PKAC (BD BioSciences, 610980; 1:1000)
antibodies. Anti-HDAC1 antibody was obtained from Santa-Cruz (sc-
6298; 1:1000), and anti-MYC antibody from Millipore (clone 4A6, 05-
724; 1:1000). MLN4924 was obtained from Millennium Pharmaceuticals.
Cloning primer sequences used in this work are given in Table S3.
pCXN2-FLAG-KCTD6, pCMV-3HA-Gli1 (G933D), pGLB3B-12Gli-Luc
and pRL-Renilla-TK plasmids have been described previously (Canettieri
et al., 2010; De Smaele et al., 2011). KCTD6 was amplified from a liver
cDNA library, inserted into pCR4-TOPO (Invitrogen) and subcloned into
pCMV-Tag2B-FLAG vector. The DNA encoding KCTD6[114–237] was
amplified from pCR4-TOPO-KCTD6, inserted into pET151 vector and
subcloned into pCMV-Tag2B-FLAG vector. pGFP-GW, pGFP-GW-
USP21, pGFP-GW-USP21CS, pGFP-C1-USP21[1–174], pGFP-C1-
USP21[1–210], pGFP-C1-USP21[Δ1–47], pGFP-C1-USP21[Δ1–121]
and pGFP-USP21[Δ1–184] plasmids have been described previously
(Urbe et al., 2012). pCDNA4-CUL3-[1-250]-FLAG and pCDNA4-CUL3-
H2×5 H5×2 [L52A, E55A, Y58A, R59A, Y62A, Y125A and R128A]
encoding Cul3[1-250] and Cul3m, respectively, were kindly provided by
Michael Rape (University of California, Berkeley, CA). MYC, MYC–
USP21 and MYC–USP21CS plasmids have been described previously
(Urbe et al., 2012). pCXN2-FLAG-KCTD11, pCXN2-FLAG-KCTD21
and pCDNA-FLAG-Gli1 have been described previously (Canettieri et al.,
2010; De Smaele et al., 2011). Murine Gli2 cDNAwas kindly provided by
Hiroshi Sasaki (Osaka University, Osaka, Japan) and sub-cloned by
means of BamHI–NotI restriction digestion in a pCDNA3 vector
engineered to contain an in-frame 5′ FLAG sequence.
CRISPR plasmids expressing Cas9–GFP from a CMV promoter and
selected gRNAs from a U6 promoter were kindly provided by Horizon
4011
RESEARCH ARTICLE Journal of Cell Science (2016) 129, 4001-4013 doi:10.1242/jcs.188516
Jo
u
rn
al
o
f
Ce
ll
Sc
ie
n
ce
Discoveries (Cambridge, UK). The gRNAs used were designed to target the
second exon of the USP21 gene, encompassing the start codon (Table S4).
PKI–Cherry plasmid was kindly provided by Oliver Rocks (Max Delbrück
Center for Molecular Medicine, Berlin). Smoothened agonist (SAG, CAS
364590-63-6) was purchased from Calbiochem.
Dephosphorylation assay
Cells were lysed in NP40 lysis buffer supplemented with 10 mM N-
ethylmaleimide, mammalian protease and phosphatase inhibitors. Lysates
(500 µg) were incubated with protein-G beads and anti-HA antibody for 1 h at
4°C. Beads were washed three times with YP-IP buffer, and once with 1×
CutSmart buffer (NEB). Beads were resuspended in 40 µl CutSmart buffer
and 3 µl of CIP (NEB) and incubated for 1 h at 30°C, and the reaction was
stopped by adding 5 mM of EDTA and subsequent incubation at 65°C for
30 min. Equivalent reaction volumes were loaded onto a gel and evaluated by
western blotting.
Modelling the C-terminal domain of KCTD6
Possible distant homology of the C-terminal domain of KCTD6 with known
domains or structures was assessed using HHpred (https://toolkit.tuebingen.
mpg.de/hhpred; Soding, 2005) and the Metaserver (https://genesilico.pl/
meta2/; Bujnicki et al., 2001). Ab initio modelling was performed with
ROSETTA (Rohl et al., 2004) or QUARK (Xu and Zhang, 2012). QUARK
returns ten ranked fold predictions derived from clustering of ab initio
models. Likewise, ten candidate structure predictions were derived from
1000 ab initiomodels using the clustering algorithm of the ROSETTA suite.
Structural similarity of predictions to known folds was assessed with DALI
(Holm and Sander, 1993), and the classifications of proteins of interest were
derived using the SCOP database (Andreeva et al., 2008).
Immunofluorescence
Cells on coverslips were rinsed oncewith PBS, fixed at−20°Cwithmethanol,
blocked in 10% goat serum, and incubated with primary and secondary
antibodies in 5% goat serum (1 h each), all in PBS. Secondary antibody was
conjugated to Alexa-Fluor-594 or Alexa-Fluor-355. Immunofluorescence
images were taken using a 3i spinning discmicroscope (63× oil objective) and
a digital camera (Hamatsu, CMOS). The images were then processed using
SlideBook software and Photoshop CS4 Version 11.0 (Adobe). Pearson’s
correlation coefficients were calculated using Coloc2 Plugin on Fiji.
Statistics
P-values are indicated as *P<0.05, **P<0.01, ***P<0.001 and
****P<0.0001 and derived either by two-tailed paired t-test or, for
multiple comparison analysis, by one-way ANOVA and Dunnett’s post-hoc
test using GraphPad Prism6.
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